PHIBRO ANIMAL HEALTH CORP financial data

Symbol
PAHC on Nasdaq
Location
Teaneck, NJ
Fiscal year end
30 June
Latest financial report
10-Q - Q4 2025 - 04 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 295% % -5.7%
Quick Ratio 169% % 8.9%
Debt-to-equity 357% % 16%
Return On Equity 31% % 311%
Return On Assets 6.7% % 267%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float $422,641,765 USD 80%
Weighted Average Number of Shares Outstanding, Basic 40,534,000 shares 0.07%
Weighted Average Number of Shares Outstanding, Diluted 40,956,000 shares 0.59%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,464,325,000 USD 32%
Operating Income (Loss) $168,819,000 USD 107%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $126,227,000 USD 274%
Income Tax Expense (Benefit) $34,137,000 USD 136%
Net Income (Loss) Attributable to Parent $92,090,000 USD 377%
Earnings Per Share, Basic 2.27 USD/shares 373%
Earnings Per Share, Diluted 2.26 USD/shares 371%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $55,486,000 USD -17%
Accounts Receivable, after Allowance for Credit Loss, Current $215,872,000 USD 13%
Inventory, Net $517,347,000 USD 21%
Other Assets, Current $54,458,000 USD -9.3%
Assets, Current $862,185,000 USD 16%
Other Long-term Investments $8,693,000 USD
Deferred Income Tax Assets, Net $19,504,000 USD -42%
Property, Plant and Equipment, Net $355,381,000 USD 5.2%
Operating Lease, Right-of-Use Asset $39,416,000 USD 5.5%
Goodwill $59,814,000 USD 9.7%
Other Assets, Noncurrent $95,107,000 USD -11%
Assets $1,405,553,000 USD 9.3%
Accounts Payable, Current $133,296,000 USD 34%
Employee-related Liabilities, Current $44,106,000 USD 27%
Liabilities, Current $282,370,000 USD 21%
Deferred Income Tax Liabilities, Net $4,197,000 USD 529%
Operating Lease, Liability, Noncurrent $32,968,000 USD 16%
Other Liabilities, Noncurrent $80,220,000 USD 17%
Liabilities $1,073,192,000 USD 3.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax $122,370,000 USD 8.8%
Retained Earnings (Accumulated Deficit) $316,959,000 USD 30%
Stockholders' Equity Attributable to Parent $332,361,000 USD 35%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $332,361,000 USD 35%
Liabilities and Equity $1,405,553,000 USD 9.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $9,302,000 USD -26%
Net Cash Provided by (Used in) Financing Activities $16,335,000 USD
Net Cash Provided by (Used in) Investing Activities $21,014,000 USD -617%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,730,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $55,486,000 USD -17%
Deferred Tax Assets, Valuation Allowance $1,279,000 USD -0.7%
Deferred Tax Assets, Gross $59,609,000 USD 46%
Operating Lease, Liability $42,867,000 USD 15%
Depreciation $43,910,000 USD 47%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $103,885,000 USD
Lessee, Operating Lease, Liability, to be Paid $51,926,000 USD 15%
Property, Plant and Equipment, Gross $633,650,000 USD 41%
Operating Lease, Liability, Current $8,959,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $8,157,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year One $10,151,000 USD 15%
Operating Lease, Weighted Average Discount Rate, Percent 0.0501 pure 5.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,059,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,232,000 USD 20%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 16,000,000 shares 0%
Unrecognized Tax Benefits $12,470,000 USD 5.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,459,000 USD 14%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $6,838,000 USD -25%
Depreciation, Depletion and Amortization $50,748,000 USD 30%
Deferred Tax Assets, Net of Valuation Allowance $58,330,000 USD 48%
Interest Expense $22,460,000 USD 35%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%